Advisors Management Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
10,270
| – | – | ﹤0.01% | 148 |
|
|
2025
Q1 | $2K | Hold |
10,270
| – | – | ﹤0.01% | 147 |
|
|
2024
Q4 | $3K | Hold |
10,270
| – | – | ﹤0.01% | 150 |
|
|
2024
Q3 | $3K | Hold |
10,270
| – | – | ﹤0.01% | 150 |
|
|
2024
Q2 | $4K | Hold |
10,270
| – | – | ﹤0.01% | 154 |
|
|
2024
Q1 | $5K | Hold |
10,270
| – | – | ﹤0.01% | 158 |
|
|
2023
Q4 | $7K | Hold |
10,270
| – | – | ﹤0.01% | 154 |
|
|
2023
Q3 | $9K | Hold |
10,270
| – | – | ﹤0.01% | 140 |
|
|
2023
Q2 | $6K | Hold |
10,270
| – | – | ﹤0.01% | 141 |
|
|
2023
Q1 | $6K | Hold |
10,270
| – | – | ﹤0.01% | 140 |
|
|
2022
Q4 | $8K | Buy |
+10,270
| New | +$8K | ﹤0.01% | 133 |
|